Boston Scientific Corp. vs. Picard Medical, Inc.
Boston Scientific Corp. (BSX) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| BSX | PMI | |
|---|---|---|
| Market Cap | $71.03 billion | $10.54 million |
| Revenue (TTM) | $21.00 billion | $6.30 million |
| Net Income (TTM) | $3.67 billion | $-27,993,000 |
BSX leads on 3 of 3 size & scale factors.
Valuation
| BSX | PMI | |
|---|---|---|
| P/E Ratio | 20.19 | — |
| Price / Book | 2.82 | 6.14 |
| Price / Sales | 3.38 | 1.67 |
BSX and PMI split the valuation factors evenly.
Profitability
| BSX | PMI | |
|---|---|---|
| Net Margin | 17.47% | -444.33% |
| Return on Equity | 14.57% | -1631.29% |
BSX leads on 2 of 2 profitability factors.
Dividend
| BSX | PMI | |
|---|---|---|
| Dividend Yield | — | 0.10% |
BSX and PMI split the dividend factors evenly.
Risk & Sentiment
| BSX | PMI | |
|---|---|---|
| Short Interest | 0.72% | 2.23% |
BSX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, PMI overview, PMI financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.